We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

AMGN Amgen Inc

-1.58 (-0.59%)
Last Updated: 13:22:19
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 1,109,447
Bid Price 267.37
Ask Price 267.46
News (1)
Day High 273.61


52 Week Range


Day Low 267.41
Company Name Stock Ticker Symbol Market Type
Amgen Inc AMGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.58 -0.59% 267.46 13:22:19
Open Price Low Price High Price Close Price Prev Close
271.73 267.41 273.61 269.04
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
27,628 1,109,447 $ 270.34 $ 299,928,545 - 211.73 - 296.67
Last Trade Time Type Quantity Stock Price Currency
13:22:25 26 $ 267.3866 USD

Amgen (AMGN) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


Amgen Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
143.06B 534.90M - 26.32B 6.55B 12.25 21.89
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Amgen News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No AMGN Message Board. Create One! See More Posts on AMGN Message Board See More Message Board Posts

Historical AMGN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week265.00273.61263.97269.322,395,2112.460.93%
1 Month260.00273.61248.38261.632,311,2847.462.87%
3 Months224.66273.61218.45248.842,504,06442.8019.05%
6 Months239.61273.61211.73239.422,431,61927.8511.62%
1 Year227.11296.67211.73249.252,551,34740.3517.77%
3 Years247.67296.67198.64238.752,702,21219.797.99%
5 Years207.41296.67165.06226.032,721,41860.0528.95%

Amgen Description

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: D: 20230927 17:37:26